BG104400A - Novel heterocyclically substituted alpha-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists - Google Patents

Novel heterocyclically substituted alpha-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists

Info

Publication number
BG104400A
BG104400A BG104400A BG10440000A BG104400A BG 104400 A BG104400 A BG 104400A BG 104400 A BG104400 A BG 104400A BG 10440000 A BG10440000 A BG 10440000A BG 104400 A BG104400 A BG 104400A
Authority
BG
Bulgaria
Prior art keywords
receptor antagonists
acid derivatives
endothelin receptor
producing
same
Prior art date
Application number
BG104400A
Other languages
Bulgarian (bg)
English (en)
Inventor
Wilhelm Amberg
Rolf Jansen
Heinz Hillen
Stefan Hergenroeder
Manfred Raschak
Liliane Unger
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of BG104400A publication Critical patent/BG104400A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/38—One oxygen atom attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
BG104400A 1997-11-14 2000-05-04 Novel heterocyclically substituted alpha-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists BG104400A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19750529A DE19750529A1 (de) 1997-11-14 1997-11-14 Neue heterocyclisch substituierte alpha-Hydroxycarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten
PCT/EP1998/007026 WO1999025701A1 (de) 1997-11-14 1998-11-04 NEUE HETEROCYCLISCH SUBSTITUIERTE α-HYDROXYCARBONSÄUREDERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS ENDOTHELINREZEPTORANTAGONISTEN

Publications (1)

Publication Number Publication Date
BG104400A true BG104400A (en) 2001-01-31

Family

ID=7848772

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104400A BG104400A (en) 1997-11-14 2000-05-04 Novel heterocyclically substituted alpha-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists

Country Status (23)

Country Link
US (1) US6358983B1 (de)
EP (1) EP1037883A1 (de)
JP (1) JP2001523671A (de)
KR (1) KR20010032083A (de)
CN (1) CN1278805A (de)
AR (1) AR017581A1 (de)
AU (1) AU752165B2 (de)
BG (1) BG104400A (de)
BR (1) BR9814157A (de)
CA (1) CA2308746A1 (de)
CO (1) CO4990973A1 (de)
DE (1) DE19750529A1 (de)
HR (1) HRP980591A2 (de)
HU (1) HUP0004341A3 (de)
ID (1) ID24819A (de)
IL (1) IL135461A0 (de)
NO (1) NO20002154L (de)
NZ (1) NZ504289A (de)
PL (1) PL340756A1 (de)
SK (1) SK4932000A3 (de)
TR (1) TR200001365T2 (de)
WO (1) WO1999025701A1 (de)
ZA (1) ZA9810425B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2568640C (en) * 2004-06-04 2011-08-09 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing irbesartan
MY146830A (en) * 2005-02-11 2012-09-28 Novartis Ag Combination of organic compounds
US7790770B2 (en) * 2005-11-23 2010-09-07 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533023B4 (de) 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
HRP980591A2 (en) 1999-08-31
BR9814157A (pt) 2000-10-03
CA2308746A1 (en) 1999-05-27
EP1037883A1 (de) 2000-09-27
HUP0004341A3 (en) 2001-12-28
US6358983B1 (en) 2002-03-19
WO1999025701A1 (de) 1999-05-27
AR017581A1 (es) 2001-09-12
IL135461A0 (en) 2001-05-20
AU752165B2 (en) 2002-09-05
ZA9810425B (en) 2000-05-15
NO20002154D0 (no) 2000-04-27
NO20002154L (no) 2000-05-12
AU1487899A (en) 1999-06-07
JP2001523671A (ja) 2001-11-27
NZ504289A (en) 2002-03-01
CN1278805A (zh) 2001-01-03
PL340756A1 (en) 2001-02-26
SK4932000A3 (en) 2001-02-12
ID24819A (id) 2000-08-24
TR200001365T2 (tr) 2000-09-21
HUP0004341A1 (hu) 2001-10-28
KR20010032083A (ko) 2001-04-16
CO4990973A1 (es) 2000-12-26
DE19750529A1 (de) 1999-05-20

Similar Documents

Publication Publication Date Title
IL66596A0 (en) Antihypertensive substituted n-alkanoylheterocyclic carboxylic acid derivatives,compositions containing them and methods for their use
BG103964A (en) SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS
ES8802493A1 (es) Procedimiento para la obtencion de amidas de acidos benzoheterociclilalcanoicos.
AU5301199A (en) Oxindole derivatives as growth hormone releasers
BG100661A (en) Aryl acetic acid derivatives
ES8406193A1 (es) Procedimiento para la preparacion de nuevas 1,4-dihidropiridinas sustituidas
MY137356A (en) Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta-opioid agonists
MXPA02001329A (es) Amidas de acido carboxilico, su produccion y su uso como medicamentos.
BG104400A (en) Novel heterocyclically substituted alpha-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists
MY113529A (en) New derivatives of imidazole n- benzyldioxole,processes for their preparation, their use as medicaments and pharmaceutical compositions containing them
ATE151750T1 (de) 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind
MY121785A (en) Hydroxamic acid derivatives as inhibitors of the production of soluble cd23
IL115085A0 (en) Bicyclic carboxamide derivatives their preparation and pharmaceutical compositions containing them
MY128754A (en) Substituted 3-aryl-3-carboxyalkyl glutaramides, method for preparing same by 4-aryl-4-cyanoheptane dicarboxylic acid cyclisation, and use thereof for preparing 3-aryl-3-hydroxyalkylpiperidines
ES8603871A1 (es) Procedimiento para preparar 2- (fenetil) -5- (3,4-metilen- dioxi)-x-hidroxibencil) -pirrolidina
BG105618A (en) Beta-amido and beta-sulphonamide derivatives of carboxylic acids, method for preparation and application as endothelin-receptor antagonists
GB9806358D0 (en) Synthesis of carboxylic acid derivatives
ES8600258A1 (es) Procedimiento de preparar derivados triazolicos
ES8600760A1 (es) Procedimiento para preparar 2-((3, 4-metilendioxi)-fenetil)-5-((3-carboxamido-4-hidroxi)- -hidroxibencil)-pirrolidina
DE60105402D1 (en) Arthropodische carboxanilide